Results 51 to 60 of about 1,581,448 (326)

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Unifying and Merging Well-trained Deep Neural Networks for Inference Stage

open access: yes, 2018
We propose a novel method to merge convolutional neural-nets for the inference stage. Given two well-trained networks that may have different architectures that handle different tasks, our method aligns the layers of the original networks and merges them
Chan, Yi-Ming   +4 more
core   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Can the g Factor Play a Role in Artificial General Intelligence Research? [PDF]

open access: yes, 2018
In recent years, a trend in AI research has started to pursue human-level, general artificial intelli-gence (AGI). Although the AGI framework is characterised by different viewpoints on what intelligence is and how to implement it in artificial systems ...
Frixione, Marcello, Serpico, Davide
core   +1 more source

Death and Suicide in Universal Artificial Intelligence

open access: yes, 2016
Reinforcement learning (RL) is a general paradigm for studying intelligent behaviour, with applications ranging from artificial intelligence to psychology and economics.
Everitt, Tom   +2 more
core   +1 more source

A critical review towards artificial general intelligence: Challenges, ethical considerations, and the path forward

open access: yesWorld Journal of Advanced Research and Reviews
The pursuit of Artificial General Intelligence (AGI) has captivated researchers and industry leaders alike, promising a future where machines possess human-like cognitive abilities. However, this ambitious endeavor is fraught with multifaceted challenges
Sedat Sonko   +4 more
semanticscholar   +1 more source

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

open access: yesMolecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié   +13 more
wiley   +1 more source

A phenomenological reply to Gary Marcus and Ernest Davis’s Rebooting AI: building artificial intelligence we can trust: contributing to the creation of general artificial intelligence

open access: yesCreativity Studies, 2023
Marcus and Davis’s Rebooting AI: Building Artificial Intelligence We Can Trust (2019) describes the narrowness of current artificial intelligence, posits constituents of human intelligence it contends artificial intelligence (AI) must reproduce to ...
Joaquin Trujillo
doaj   +1 more source

Playing Smart - Artificial Intelligence in Computer Games [PDF]

open access: yes, 2003
: With this document we will present an overview of artificial intelligence in general and artificial intelligence in the context of its use in modern computer games in particular. To this end we will firstly provide an introduction to the terminology of
Anderson, Eike F.
core   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy